Analysis of the genomic landscape in ALK+ NSCLC patients identifies novel aberrations associated with clinical outcomes

ABSTRACT: Expression data of primary and metastasic tissues from ALK+ NSCLC patients (Anaplastic lymphoma kinase fusion positive non-small cell lung carcinoma)

ORGANISM(S): Homo sapiens

PROVIDER: GSE125864 | GEO | 2020/02/28

REPOSITORIES: GEO